tm logo
CYTOPE
FORMALIZED

on 11 Oct 2023

Last Applicant/ Owned by

PROTHENA PLATFORM TECHNOLOGIES LIMITED

77 Sir John Rogerson's Quay,Block C, Grand Canal Docklands,Dublin 2D02 VK60

IE

Serial Number

2286275 filed on 12th Jul 2023

CYTOPE

Trademark usage description

biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of autoimmune, metastatic, hematologic, onco Read More

Classification Information


Class [005]
Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of autoimmune, metastatic, hematologic, oncologic, ocular and neurologic diseases, conditions and disorders; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders associated with misfolded proteins; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders affecting the central nervous system; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of amyloidosis, psoriasis, psoriatic arthritis, rheumatoid arthritis, dermatitis, host and graft rejections, Alzheimer's and Parkinson's-disease associated neuropsychiatric disorders, insulin resistance, metabolic syndrome and diabetes.


Classification kind code

12

Class [042]
Research and development in the pharmaceutical and biotechnology fields.


Classification kind code

12

Class [045]
Licensing of intellectual property in the field of biotechnology.


Classification kind code

12

Mark Details


Serial Number

2286275

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 256
on 12th Aug 2024
Notification of Possible Opposition Sent
Submitted for opposition 257
on 12th Oct 2023
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 11th Oct 2023
Created
Submitted for opposition 31
on 11th Oct 2023
Formalized
Submitted for opposition 30
on 12th Jul 2023
Filed
Submitted for opposition 228
on 12th Jul 2023
International Registration